Patents by Inventor H. David Humes

H. David Humes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cytopheresis cartridges and use thereof
    Patent number: 11866730
    Abstract: The present invention relates to a cytopheretic cartridge for use in treating and/or preventing inflammatory conditions within a subject and to related methods. More particularly, the invention relates to a cytopheretic cartridge that includes a housing and, disposed within the housing, a solid support capable of sequestering activated leukocytes and/or platelets.
    Type: Grant
    Filed: September 13, 2021
    Date of Patent: January 9, 2024
    Assignee: SeaStar Medical, Inc.
    Inventors: H. David Humes, Deborah A. Buffington, Christopher J. Pino
  • SELECTIVE CYTOPHERESIS DEVICES AND RELATED METHODS THEREOF
    Publication number: 20230277746
    Abstract: The present invention relates to systems and devices to treat and/or prevent inflammatory conditions within a subject and to related methods. More particularly, the invention relates to systems, devices, and related methods that sequester leukocytes and/or platelets and then inhibit their inflammatory action.
    Type: Application
    Filed: October 3, 2022
    Publication date: September 7, 2023
    Inventors: H. David Humes, Deborah Buffington
  • Cartridge and method for increasing myocardial function
    Patent number: 11439739
    Abstract: The present invention relates to a cytopheretic cartridge for use in treating and/or preventing inflammatory conditions that affect myocardial function and to related methods. The cartridge can be used in treating a subject with myocardial dysfunction, such as a subject with chronic heart failure and/or acute decompensated heart failure.
    Type: Grant
    Filed: July 22, 2020
    Date of Patent: September 13, 2022
    Assignee: SeaStar Medical, Inc.
    Inventors: H. David Humes, Deborah A. Buffington
  • CYTOPHERESIS CARTRIDGES AND USE THEREOF
    Publication number: 20220177838
    Abstract: The present invention relates to a cytopheretic cartridge for use in treating and/or preventing inflammatory conditions within a subject and to related methods. More particularly, the invention relates to a cytopheretic cartridge that includes a housing and, disposed within the housing, a solid support capable of sequestering activated leukocytes and/or platelets.
    Type: Application
    Filed: September 13, 2021
    Publication date: June 9, 2022
    Inventors: H. David Humes, Deborah A. Buffington, Christopher J. Pino
  • Cytopheresis cartridges and use thereof
    Patent number: 11118162
    Abstract: The present invention relates to a cytopheretic cartridge for use in treating and/or preventing inflammatory conditions within a subject and to related methods. More particularly, the invention relates to a cytopheretic cartridge that includes a housing and, disposed within the housing, a solid support capable of sequestering activated leukocytes and/or platelets.
    Type: Grant
    Filed: July 31, 2017
    Date of Patent: September 14, 2021
    Assignee: SeaStar Medical, Inc.
    Inventors: H. David Humes, Deborah A. Buffington, Christopher J. Pino
  • CARTRIDGE AND METHOD FOR INCREASING MYOCARDIAL FUNCTION
    Publication number: 20210138142
    Abstract: The present invention relates to a cytopheretic cartridge for use in treating and/or preventing inflammatory conditions that affect myocardial function and to related methods. The cartridge can be used in treating a subject with myocardial dysfunction, such as a subject with chronic heart failure and/or acute decompensated heart failure.
    Type: Application
    Filed: July 22, 2020
    Publication date: May 13, 2021
    Inventors: H. David Humes, Deborah A. Buffington
  • Cartridge and method for increasing myocardial function
    Patent number: 10722637
    Abstract: The present invention relates to a cytopheretic cartridge for use in treating and/or preventing inflammatory conditions that affect myocardial function and to related methods. The cartridge can be used in treating a subject with myocardial dysfunction, such as a subject with chronic heart failure and/or acute decompensated heart failure.
    Type: Grant
    Filed: April 20, 2017
    Date of Patent: July 28, 2020
    Assignee: SeaStar Medical, Inc.
    Inventors: H. David Humes, Deborah A. Buffington
  • Cartridge and method for increasing myocardial function
    Patent number: 10695482
    Abstract: The present invention relates to a cytopheretic cartridge for use in treating and/or preventing inflammatory conditions that affect myocardial function and to related methods. The cartridge can be used in treating a subject with myocardial dysfunction, such as a subject with chronic heart failure and/or acute decompensated heart failure.
    Type: Grant
    Filed: June 20, 2017
    Date of Patent: June 30, 2020
    Assignee: SeaStar Medical, Inc.
    Inventors: H. David Humes, Deborah A. Buffington, Christopher J. Pino
  • SELECTIVE CYTOPHERESIS DEVICES AND RELATED METHODS THEREOF
    Publication number: 20200038578
    Abstract: The present invention relates to systems and devices to treat and/or prevent inflammatory conditions within a subject and to related methods. More particularly, the invention relates to systems, devices, and related methods that sequester leukocytes and/or platelets and then inhibit their inflammatory action.
    Type: Application
    Filed: March 20, 2019
    Publication date: February 6, 2020
    Inventors: H. David Humes, Deborah Buffington
  • CYTOPHERESIS CARTRIDGES AND USE THEREOF
    Publication number: 20180171293
    Abstract: The present invention relates to a cytopheretic cartridge for use in treating and/or preventing inflammatory conditions within a subject and to related methods. More particularly, the invention relates to a cytopheretic cartridge that includes a housing and, disposed within the housing, a solid support capable of sequestering activated leukocytes and/or platelets.
    Type: Application
    Filed: July 31, 2017
    Publication date: June 21, 2018
    Inventors: H. David Humes, Deborah A. Buffington, Christopher J. Pino
  • CARTRIDGE AND METHOD FOR INCREASING MYOCARDIAL FUNCTION
    Publication number: 20180126059
    Abstract: The present invention relates to a cytopheretic cartridge for use in treating and/or preventing inflammatory conditions that affect myocardial function and to related methods. The cartridge can be used in treating a subject with myocardial dysfunction, such as a subject with chronic heart failure and/or acute decompensated heart failure.
    Type: Application
    Filed: June 20, 2017
    Publication date: May 10, 2018
    Inventors: H. David Humes, Deborah A. Buffington, Christopher J. Pino
  • CARTRIDGE AND METHOD FOR INCREASING MYOCARDIAL FUNCTION
    Publication number: 20180093028
    Abstract: The present invention relates to a cytopheretic cartridge for use in treating and/or preventing inflammatory conditions that affect myocardial function and to related methods. The cartridge can be used in treating a subject with myocardial dysfunction, such as a subject with chronic heart failure and/or acute decompensated heart failure.
    Type: Application
    Filed: April 20, 2017
    Publication date: April 5, 2018
    Inventors: H. David Humes, Deborah A. Buffington
  • SELECTIVE CYTOPHERESIS DEVICES AND RELATED METHODS THEREOF
    Publication number: 20170246208
    Abstract: The present invention relates to systems and devices to treat and/or prevent inflammatory conditions within a subject and to related methods. More particularly, the invention relates to systems, devices, and related methods that sequester leukocytes and/or platelets and then inhibit their inflammatory action.
    Type: Application
    Filed: October 14, 2016
    Publication date: August 31, 2017
    Inventors: H. David Humes, Deborah Buffington
  • Selective cytopheresis devices and related methods thereof
    Patent number: 9498566
    Abstract: The present invention relates to systems and devices to treat and/or prevent inflammatory conditions within a subject and to related methods. More particularly, the invention relates to systems, devices, and related methods that sequester leukocytes and/or platelets and then inhibit their inflammatory action.
    Type: Grant
    Filed: June 25, 2012
    Date of Patent: November 22, 2016
    Assignees: CYTOPHERX, INC., THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: H. David Humes, Deborah Buffington
  • Selective cytopheresis devices and related methods thereof
    Patent number: 9341626
    Abstract: The present invention relates to systems and devices to treat and/or prevent inflammatory conditions within a subject and to related methods. More particularly, the invention relates to systems, devices, and related methods that sequester leukocytes and/or platelets and then inhibit their inflammatory action.
    Type: Grant
    Filed: April 15, 2011
    Date of Patent: May 17, 2016
    Assignees: CYTOPHERX, INC., THE REGENTS OF THE UNIVERSITY OF MICHIGAN
    Inventors: H. David Humes, Deborah Buffington
  • Selective cytopheresis devices and related methods thereof
    Patent number: 9128093
    Abstract: The present invention relates to systems and devices to treat and/or prevent inflammatory conditions within a subject and to related methods. More particularly, the invention relates to systems, devices, and related methods that sequester leukocytes and/or platelets and then inhibit their inflammatory action.
    Type: Grant
    Filed: June 25, 2012
    Date of Patent: September 8, 2015
    Assignees: THE REGENTS OF THE UNIVERSITY OF MICHIGAN, CYTOPHERX, INC.
    Inventors: H. David Humes, Deborah Buffington
  • CARTRIDGE AND METHOD FOR INCREASING MYOCARDIAL FUNCTION
    Publication number: 20150246169
    Abstract: The present invention relates to a cytopheretic cartridge for use in treating and/or preventing inflammatory conditions that affect myocardial function and to related methods. The cartridge can be used in treating a subject with myocardial dysfunction, such as a subject with chronic heart failure and/or acute decompensated heart failure.
    Type: Application
    Filed: April 14, 2014
    Publication date: September 3, 2015
    Inventors: H. David Humes, Deborah A. Buffington, Christopher J. Pino
  • CARTRIDGE AND METHOD FOR INCREASING MYOCARDIAL FUNCTION
    Publication number: 20150129497
    Abstract: The present invention relates to a cytopheretic cartridge for use in treating and/or preventing inflammatory conditions that affect myocardial function and to related methods. The cartridge can be used in treating a subject with myocardial dysfunction, such as a subject with chronic heart failure and/or acute decompensated heart failure.
    Type: Application
    Filed: July 9, 2014
    Publication date: May 14, 2015
    Inventors: H. David Humes, Deborah A. Buffington
  • CYTOPHERESIS CARTRIDGES AND USE THEREOF
    Publication number: 20130288370
    Abstract: The present invention relates to a cytopheretic cartridge for use in treating and/or preventing inflammatory conditions within a subject and to related methods. More particularly, the invention relates to a cytopheretic cartridge that includes a housing and, disposed within the housing, a solid support capable of sequestering activated leukocytes and/or platelets.
    Type: Application
    Filed: October 14, 2011
    Publication date: October 31, 2013
    Applicant: CYTOPHERX, INC.
    Inventors: H. David Humes, Deborah Buffington, Christopher J. Pino
  • Selective cytopheresis devices and related methods thereof
    Patent number: 8430832
    Abstract: The present invention relates to systems and devices to treat and/or prevent inflammatory conditions within a subject and to related methods. More particularly, the invention relates to systems, devices, and related methods that sequester leukocytes and/or platelets and then inhibit their inflammatory action.
    Type: Grant
    Filed: June 30, 2010
    Date of Patent: April 30, 2013
    Assignees: The Regents of the University of Michigan, CytoPherx, Inc.
    Inventors: H. David Humes, Deborah Buffington